Dinesh V. Ph D. Patel, President and CEO at Protagonist Therapeutics, Inc (PTGX), sold 100,000 shares at $149.11 ($14.9M) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Scheduled sale ($14.9M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.11 | 65,761 | $9.8M | 65.9% |
| 2 | $148.52 | 34,239 | $5.1M | 34.1% |
| Total | $148.91 avg | 100,000 | $14.9M | 100% |
| Filing → |
| PTGX | SELL | 2026-01-27 | $4.1M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $2.8M | — | Filing → |
| PTGX | SELL | 2025-07-28 | $1.1M | — | Filing → |